Hyderabad: Youth Selling Tydol Drug Illegally Held By DCA

Hyderabad: Officials from the Drugs Control Administration (DCA) busted a drug racket in the Old City of Hyderabad in raids on Wednesday, May 8. Acting on credible information, DCA officials raided different areas in the Charminar area along with the police and held one resident who was selling Tydol 100 tablets illegally to youngsters.

DCA officers found that Arshad Khan, a resident Aman Nagar A, Yakutpura, was illegally selling Tydol 100 tablets (Tapentadol tablets 100 mg) at the Charminar Bus Stand parking area, New Shahalibanda Road. Officers seized 400 tablets of Tydol 100 tablets during the raid. The total worth of the stocks seized was Rs. 23,000, said V B Kamalasan Reddy, director general of DCA.

Tapentadol is a centrally acting opioid analgesic used for the management of moderate to severe pain for both acute (following injury, surgery, etc.) and chronic musculoskeletal pain. It works by acting on the opioid receptors in the brain and spinal cord, thereby altering the way the body perceives and responds to pain, stated Kamalasan Reddy. Due to its potential for abuse and addiction, Tapentadol has been classified as a Schedule H1 drug under the Drugs and Cosmetics Act.

Arshad Khan, who was selling the drug in the Charminar area, does not possess any drug licence and was illegally selling the habit-forming drug Tapentadol addicts, stated the DCA in a release.

Schedule H1 drugs are those that have a high potential for abuse or indiscriminate use and are subject to stricter regulations regarding their sale, said Kamalasan Reddy. The inclusion of ‘Tapentadol’ in Schedule H1 means that it can only be sold by retail pharmacies with a prescription from a registered medical practitioner, he added.

T. Rajamouli, Assistant Director, Hyderabad zone, B. Lakshmi, Drugs Inspector, Charminar and S. Naveen, sub-inspector of police, Hussaini Alam police station were among the officers who carried out the raid. Further investigation will be carried out, and action will be taken as per the law against all the offenders, stated the DCA.

Related Posts

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

NEW DELHI: Medical technology innovation is entering a new phase, with advanced cardiac implants, incisionless brain surgery, blood-based cancer screening, smart insulin delivery and real-time kidney-function monitoring among the technologies…

Three arrested after liquor bottles found at pharma firm

Patna: Three people were arrested and sent to jail after a large quantity of liquor bottles was found at Cellulas Pharma Private Limited in Kankarbagh during a raid by the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

Three arrested after liquor bottles found at pharma firm

Three arrested after liquor bottles found at pharma firm

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources

Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources